What We're Reading: Page 129
Industry reads hand-picked by our editors
Jan 07, 2022
Jan 06, 2022
-
STAT
Top hospitals aren’t offering Alzheimer's drug Aduhelm
-
TechCrunch
"How can you understand life if you don’t look at it live?" — Eikon Therapeutics rakes in $518M
-
San Francisco Business Times
Clinical trial sets stage for biotech's goal to beat a rare disease
-
Axios
IBM tries to sell Watson Health again
Jan 05, 2022
Jan 04, 2022
-
The Wall Street Journal
The Elizabeth Holmes Verdict: Theranos Founder Is Guilty on Four of 11 Charges in Fraud Trial
-
The Washington Post
India's Corbevax vaccine was developed at Texas Children's Hospital. It expects nothing in return.
-
BioCentury
Former FDA Commissioner Crawford dead at 83
-
Reuters
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Jan 03, 2022
-
Nasdaq
Here’s What Happened to Biotech This Year
-
The New York Times
Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision
-
Associated Press
New York jury holds drugmaker Teva liable in opioid crisis
-
Reuters
Samsung BioLogics says report on Biogen deal talks untrue
-
POLITICO
Biden officials now fear booster programs will limit global vaccine supply
-
STAT
BridgeBio’s heart drug misses primary goal in pivotal study
Dec 23, 2021
-
The Wall Street Journal
Novavax Says Early Data Shows Covid-19 Vaccine Protects Against Omicron
-
Evaluate Vantage
Argenx’s independent streak approaches its biggest test
-
STAT
How medicine erased Black women from a 'white man's disease'
Dec 22, 2021
-
The New York Times
Hospitals Scramble as Antibody Treatments Fail Against Omicron
-
Nikkei Asia
Japan says Eisai-Biogen's Alzheimer drug hard to assess
-
Reuters
Pardes to go public, says COVID-19 antiviral pill does not need booster
-
The Wall Street Journal
Prominent Harvard Professor Found Guilty of Lying About China Ties
Previous
